Min Jie, Luo Yulin, Fu Qian, Sun Xiaona, Mi Lan, Shen Yutian, Wang Hui
Department of Nephrology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, 100045, China.
Department of Nephrology, Key Laboratory of Basic and Clinical Pediatric Nephrology, Baoding Hospital of Beijing Children's Hospital, Regional Center for Children's Health, Capital Medical University, Baoding, 071000, China.
Eur J Med Res. 2025 Apr 15;30(1):276. doi: 10.1186/s40001-025-02522-6.
Renal coloboma syndrome (RCS) is a rare autosomal dominant genetic disorder associated with the paired box gene 2 (PAX2). Over the past three decades, PAX2 variants have manifested with vast phenotype and genotype heterogeneity, with limited experience gained regarding its clinical progression and management strategies.
We included nine Chinese children diagnosed with PAX2-related disorder at Beijing Children's Hospital. The medical records were retrospectively reviewed, and the demographic data, clinical manifestations, genetic testing results, imaging examination findings, laboratory tests, and renal biopsy results were recorded and analyzed.
Eight distinct PAX2 pathogenic variants, including four novel variants, were identified in nine children. All patients exhibited developmental abnormalities of the urinary system, while two presented with ocular abnormalities with retinal myelinated nerve fibers identified as a novel manifestation of PAX2-related disorder. Cranial imaging examinations were performed on three patients, revealing vascular anatomical abnormalities. Five patients received empirical treatment with angiotensin-converting enzyme inhibitors (ACEIs), resulting in varied therapeutic outcomes.
PAX2 variants exhibit significant clinical diversity, and our findings further expand the genotype-phenotype spectrum of PAX2-related disorder. The variable efficacy of ACEIs highlights the importance of personalized evaluation and treatment strategies and extended follow-up periods in the future.
肾裂综合征(RCS)是一种罕见的常染色体显性遗传病,与配对盒基因2(PAX2)相关。在过去三十年中,PAX2变异表现出广泛的表型和基因型异质性,关于其临床进展和管理策略的经验有限。
我们纳入了在北京儿童医院被诊断为PAX2相关疾病的9名中国儿童。对病历进行回顾性审查,记录并分析人口统计学数据、临床表现、基因检测结果、影像学检查结果、实验室检查以及肾活检结果。
在9名儿童中鉴定出8种不同的PAX2致病变异,包括4种新变异。所有患者均表现出泌尿系统发育异常,其中2例出现眼部异常,视网膜有髓神经纤维被确定为PAX2相关疾病的一种新表现。对3例患者进行了头颅影像学检查,发现血管解剖异常。5例患者接受了血管紧张素转换酶抑制剂(ACEIs)的经验性治疗,治疗效果各异。
PAX2变异表现出显著的临床多样性,我们的研究结果进一步扩展了PAX2相关疾病的基因型-表型谱。ACEIs的疗效差异突出了个性化评估和治疗策略以及未来延长随访期的重要性。